Top Markets
#1 Palladium Network Palladium Network +27.90%
#2 Ankr Network Ankr Network +20.08%
#3 Fake World Assets Fake World Assets +8.58%
#4 Status Status +8.22%
#5 Pons Pons +6.97%
#6 Ribbita by Virtuals Ribbita by Virtuals +6.85%
#7 would would +6.62%
#8 WAX WAX +6.52%
#9 edgeX edgeX +6.10%
#10 Hive Hive +4.94%
Coin of the day
Palladium Network Palladium Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Classifica tra le azioni #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Prezzo delle azioni
$5.84
Ultima sincronizzazione: 2025-04-02
Capitalizzazione di mercato
$224.09M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Nevro Corp. (NVRO)

Categoria

Healthcare
Utile per Nevro Corp. (NVRO)
Utile nel Dec 2024 TTM: $-112.35M
Secondo gli ultimi rapporti finanziari di Nevro Corp., gli utili attuali della società sono $-112.35M. Nel 2023, la società ha registrato un utile di $-97.86M, una diminuzione rispetto a agli utili del 2022, che erano di $4.26M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Nevro Corp. dal 2012 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-112.35M 0.00%
2024 $-112.35M 14.80%
2023 $-97.86M -2,395.00%
2022 $4.26M -103.26%
2021 $-130.83M 59.16%
2020 $-82.20M -19.48%
2019 $-102.09M 110.76%
2018 $-48.44M 37.41%
2017 $-35.25M 16.90%
2016 $-30.16M -54.49%
2015 $-66.27M 119.41%
2014 $-30.20M 17.74%
2013 $-25.65M 36.41%
2012 $-18.81M 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -6,785.60%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -4,682.27%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -5,051.67%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -3,536.70%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -1,361.82%
US